ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, whic...
Q1 2026
May 12, 2026
FY 2025
Mar 25, 2026
Q4 2025
Q3 2025
Nov 12, 2025
Q2 2025
Aug 13, 2025